Biomedtracker

Report Library

Chronic Lymphocytic Leukemia (CLL) Report

February 06, 2015

This report provides a snapshot of approved drugs and drug development for the treatment of Chronic Lymphocytic Leukemia (CLL). This report includes analysis on the following topics:

Key clinical trial data and comments on potential future plans for approved and experimental CLL therapies.
Trends in CLL drug development with respect to molecular class and other features.
Historical revenues and market directions for CLL drugs and drug candidates.

We also performed an interview with a KOL who specializes in treating lymphoid malignancies, and we performed two surveys (the first of which is available here) of hematology-oncologists regarding their current prescribing practices for CLL treatment. Sample KOL quotes are provided in this report.

For the full report, please download the PDF version at the top of this page.

For our disclosures, please read the BioMedTracker Research Standards.

Disease Group Covered:

Oncology

Indications Covered:

Castleman's Disease

Additional Resources: